Alcyone Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Alcyone Therapeutics's estimated annual revenue is currently $6.4M per year.
- Alcyone Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Alcyone Therapeutics has 41 Employees.
- Alcyone Therapeutics grew their employee count by -11% last year.
Alcyone Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | CMO and Global Head R&D | Reveal Email/Phone |
3 | VP, Human Resources | Reveal Email/Phone |
4 | VP & Head R&D, Precision Delivery | Reveal Email/Phone |
5 | EVP & Global Head Technology | Reveal Email/Phone |
6 | Head Development, Precision Delivery | Reveal Email/Phone |
7 | VP Research, Drug Delivery, & CSF Sciences | Reveal Email/Phone |
8 | Head R&D, Precision Delivery | Reveal Email/Phone |
9 | VP Product Development | Reveal Email/Phone |
10 | VP, Device Development | Reveal Email/Phone |
Alcyone Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Alcyone Therapeutics?
Alcyone Therapeutics is a biotechnology company developing precision therapies for neurological disorders with high unmet medical needs. The company integrates innovation in neuroscience, precision dosing platforms and in-house manufacturing capabilities to deliver transformative therapies to patients. Alcyone leverages the synergy between FalconTM, the company’s proprietary intrathecal precising dosing platform that incorporates deep knowledge of CSF fluid dynamics, computational modeling and bioengineering, and multiple novel genetic therapy platforms developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital (AWRI). This comprehensive approach allows for the optimization of central nervous system (CNS) dosing and delivery to better target the pathophysiology and anatomy specific to various neurological disease areas. Alcyone’s lead programs target the treatment of Rett syndrome and IGHMBP2-Related Diseases (IRD).
keywords:N/A
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Lowell
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.8M | 42 | 5% | N/A |
#2 | $3.5M | 42 | -2% | N/A |
#3 | $8.2M | 43 | 8% | N/A |
#4 | $5.6M | 44 | 10% | N/A |
#5 | $7.6M | 45 | -6% | N/A |